Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2022

04-07-2022 | Kaposi's Sarcoma-Associated Herpesvirus | IM - CASE RECORD

An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis

Authors: Francesca Ambrogio, Carmelo Laface, Federico Perosa, Lucia Lospalluti, Girolamo Ranieri, Serena De Prezzo, Marcella Prete, Gerardo Cazzato, Fabrizio Guarneri, Paolo Romita, Caterina Foti

Published in: Internal and Emergency Medicine | Issue 8/2022

Login to get access

Excerpt

Dr. Ambrogio: Our case is that of an 82-year-old female patient. In 2015, she developed inflammation affecting knees, ankles, wrists, and proximal interphalangeal joints. Consequently, she was diagnosed with RA. She was initially treated with methylprednisolone 4 mg/daily and methotrexate 15 mg/week despite low clinical remission. In January 2017, she suspended methotrexate due to radiologic detection of RA-associated interstitial lung disease. Therefore, she undertook therapy with azathioprine 200 mg/daily and then with salazopirine 1000 mg/daily. However, both drugs were interrupted because of adverse events. Thus, in September 2017 she started abatacept 125 mg/week in association with prednisone 5 mg/daily obtaining a significant clinical amelioration. …
Literature
10.
go back to reference Martínez-Martínez ML, Pérez-García LJ, Escario-Travesedo E, Ribera-Vaquerizo PA (2010) Kaposi sarcoma associated with infliximab treatment. Actas dermo-sifiliograficas 101:462–464CrossRefPubMed Martínez-Martínez ML, Pérez-García LJ, Escario-Travesedo E, Ribera-Vaquerizo PA (2010) Kaposi sarcoma associated with infliximab treatment. Actas dermo-sifiliograficas 101:462–464CrossRefPubMed
Metadata
Title
An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis
Authors
Francesca Ambrogio
Carmelo Laface
Federico Perosa
Lucia Lospalluti
Girolamo Ranieri
Serena De Prezzo
Marcella Prete
Gerardo Cazzato
Fabrizio Guarneri
Paolo Romita
Caterina Foti
Publication date
04-07-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03025-6

Other articles of this Issue 8/2022

Internal and Emergency Medicine 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.